NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.

Chmura SJ, Winter KA, Woodward WA, Borges VF, Salama JK, Al-Hallaq HA, Matuszak MM, Milano MT, Jaskowiak NT, Jagsi R, Kuhn P, Lucci A, Meas S, Shishido SN, Mason J, Bazan JG Jr, Nordal RA, Lee DY, Smith BD, Gabos Z, Ye JC, Kahn ST, Vallow LA, Zoberi I, Razaq W, Mishra MV, Lupinacci KM, Moughan J, Mamounas EP, White JR

Open source

DOI: 10.1200/jco-26-00201
Published: 2026 Oct 7
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-26-00201,
  title = {NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.},
  author = {Chmura SJ and Winter KA and Woodward WA and Borges VF and Salama JK and Al-Hallaq HA and Matuszak MM and Milano MT and Jaskowiak NT and Jagsi R and Kuhn P and Lucci A and Meas S and Shishido SN and Mason J and Bazan JG Jr and Nordal RA and Lee DY and Smith BD and Gabos Z and Ye JC and Kahn ST and Vallow LA and Zoberi I and Razaq W and Mishra MV and Lupinacci KM and Moughan J and Mamounas EP and White JR},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-26-00201},
  url = {https://doi.org/10.1200/jco-26-00201}
}

RIS

TY  - JOUR
TI  - NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.
AU  - Chmura SJ
AU  - Winter KA
AU  - Woodward WA
AU  - Borges VF
AU  - Salama JK
AU  - Al-Hallaq HA
AU  - Matuszak MM
AU  - Milano MT
AU  - Jaskowiak NT
AU  - Jagsi R
AU  - Kuhn P
AU  - Lucci A
AU  - Meas S
AU  - Shishido SN
AU  - Mason J
AU  - Bazan JG Jr
AU  - Nordal RA
AU  - Lee DY
AU  - Smith BD
AU  - Gabos Z
AU  - Ye JC
AU  - Kahn ST
AU  - Vallow LA
AU  - Zoberi I
AU  - Razaq W
AU  - Mishra MV
AU  - Lupinacci KM
AU  - Moughan J
AU  - Mamounas EP
AU  - White JR
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-26-00201
UR  - https://doi.org/10.1200/jco-26-00201
ER  -

APA

SJ, C., KA, W., WA, W., VF, B., JK, S., HA, A., MM, M., MT, M., NT, J., R, J., P, K., A, L., S, M., SN, S., J, M., Jr, B. J., RA, N., DY, L., BD, S., Z, G., JC, Y., ST, K., LA, V., I, Z., W, R., MV, M., KM, L., J, M., EP, M., & JR, W. (2026). NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-26-00201

Source records

pubmed · retrieved 2026-11-10T11:08:05.946Z